Impact of Initial Valve Type on Reintervention for TAVR Failure: From the EXPLANTORREDO-TAVR International Registry
Authors:
- Syed ZaidSZSyed Zaid
- Tsuyoshi KanekoTKTsuyoshi Kaneko
- Ole De BackerOBOle De Backer
- Sachin S. GoelSGSachin S. Goel
- Paolo DentiPDPaolo Denti
- Thomas ModineTMThomas Modine
- Tamim N. NazifTNTamim N. Nazif
- Martin B. LeonMLMartin B. Leon
- Michael J. MackMMMichael J. Mack
- Vinayak N. BapatVBVinayak N. Bapat
- Gilbert H. L. TangGTGilbert H. L. Tang
- Moritz Wyler von BallmoosMBMoritz Wyler von Ballmoos
- 11 September 2026
- journal article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
Abstract
BACKGROUND: As transcatheter aortic valve replacement (TAVR) expands to younger patients, there is limited data on the impact of TAV type on outcomes of TAVR-explant and redo-TAVR for TAVR failure. We sought to compare outcomes of reintervention for failed balloon-expandable valves (BEV) versus self-expanding valves (SEV). METHODS: From May 2009 to February 2022, 553 patients from 29 centers in the international EXPLANTORREDO-TAVR registry underwent redo-TAVR or TAVR-explant for TAVR failure during a separate admission from index TAVR. Mechanically expanding valves and explantation for endocarditis were excluded. 158 (41.4%) failed-BEV were compared with 224 (58.6%) failed-SEV, and outcomes were reported at 30 days and 1 year. RESULTS: Mean age at reintervention was 75.5±9.3 years, and 40.6% were female. Failed-BEV had higher proportion of structural valve deterioration (73.4% versus 46.1% in failed-SEV; P P =0.022) and fewer paravalvular leak (18.2% versus 41.1%; P P P =0.92), with cross-platform redo-TAVR favored in both groups (58.1% of failed-BEV received SEV; 59.2% of failed-SEV received BEV; P =0.016). Compared with failed-SEV, reintervention for failed-BEV had similar mortality at 30 days (8.7% versus 8.0%; P =0.85) and 1 year (24.3% versus 21.5%; P =0.65), with no differences in risk-adjusted 3-year cumulative mortality when stratified by reintervention type (redo TAVR: adjusted hazard ratio, 1.15 [0.61–2.20]; ref: failed-BEV); TAVR-explant: adjusted hazard ratio, 0.84 [0.46–1.54]). CONCLUSIONS: Failed-BEV and failed-SEV showed distinct failure mechanisms and timing of reintervention, but initial valve type did not impact reintervention strategy or survival after redo-TAVR or TAVR-explant.Keywords
This publication has 17 references indexed in Scilit:
- Six-Year Outcomes After Transcatheter vs Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic StenosisJACC, 2026
- Surgical Explantation of Failed Transcatheter Aortic Valve ReplacementThe Annals of Thoracic Surgery, 2023
- Explant vs Redo-TAVR After Transcatheter Valve FailureJACC: Cardiovascular Interventions, 2023
- Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High RiskJAMA Cardiology, 2023
- Outcomes of Redo Transcatheter Aortic Valve Replacement According to the Initial and Subsequent Valve TypeJACC: Cardiovascular Interventions, 2022
- Surgical Explantation After TAVR FailureJACC: Cardiovascular Interventions, 2021
- Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical ResearchJACC, 2021
- STS-ACC TVT Registry of Transcatheter Aortic Valve ReplacementJACC, 2020
- Repeat Transcatheter Aortic Valve Replacement for Transcatheter Prosthesis DysfunctionJACC, 2020
- Meta-Analysis of Outcomes of Transcatheter Aortic Valve Implantation Among Patients With Low Gradient Severe Aortic StenosisThe American Journal of Cardiology, 2019